Details of the Drug

General Information of Drug (ID: DMTW0GD)

• Drug Name: (2-biphenyl-3-yl-ethyl)-dimethyl-amine
• Synonyms: CHEMBL234882

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

• Drug Type: Small molecular drug
• #Ro5 Violations (Lipinski): 0:
  Molecular Weight (mw); 225.33
  Logarithm of the Partition Coefficient (xlogp); 3.8
  Rotatable Bond Count (rotbonds); 4
  Hydrogen Bond Donor Count (hbonddonor); 0
  Hydrogen Bond Acceptor Count (hbondacc); 1
• Chemical Identifiers:
  Formula: C16H19N
  IUPAC Name: N,N-dimethyl-2-(3-phenylphenyl)ethanamine
  Canonical SMILES: CN(C)CCC1=CC(=CC=C1)C2=CC=CC=C2
  InChI: InChI=1S/C16H19N/c1-17(2)12-11-14-7-6-10-16(13-14)15-8-4-3-5-9-15/h3-10,13H,11-12H2,1-2H3
  InChIKey: ZMTHYJFLTGNPHJ-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 44431718
  TTD ID: D0B4LD

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
5-HT 7 receptor (HTR7)	TTO9X1H	5HT7R_HUMAN	Inhibitor	[1]

Molecular Expression Atlas of This Drug

• The Studied Disease: Discovery agent
• ICD Disease Classification: N.A.

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
5-HT 7 receptor (HTR7)	DTT	HTR7	9.79E-01	-0.08	-0.32

References

• [1] Novel aminoethylbiphenyls as 5-HT7 receptor ligands. Bioorg Med Chem Lett. 2007 Jun 1;17(11):3018-22.